AMBU-B Ambu A/S

CPH · DK · Healthcare · Medical Devices · ambu.com

67.45DKK+0.15%Mkt Cap: 2.56B $P/E: 35.08Today

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, includin…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

Key Statistics

Company

Market Cap2.56B USD

Enterprise Value2.58B USD

Revenue (TTM)908.43M USD

Gross Profit466.23M USD

Net Income (TTM)34.23M USD

Revenue/Share23.53 DKK

Last Price67.45 DKK

Fiscal Year EndSep 2025

MR QuarterJun 2026

Employees5.2K

CountryDK

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)35.08

P/E (Forward)22.19

PEG2.85

EV/EBITDA20.35

EV/Revenue2.83

P/S2.81

P/B2.89

EPS (TTM)1.92

EPS (Forward)3.04

52W Range

56.2520% of range111.80

52W High111.80 DKK

52W Low56.25 DKK

Profitability

Gross Margin59.38%

Oper. Margin13.48%

EBITDA Margin13.93%

Profit Margin4.36%

ROE4.20%

ROA3.28%

Growth

Revenue Growth8.80%

Earnings Growth28.30%

Cash Flow & Leverage

Operating CF118.42M USD

CapEx (TTM)42.09M USD

FCF Margin3.31%

FCF Yield1.18%

Net Debt-18.35M USD

Net Debt/EBITDA-0.14

Balance Sheet

Debt/Equity0.10

Current Ratio2.77

Quick Ratio1.58

Book Value/Sh23.33 DKK

Cash/Share2.67 DKK

Dividends

Fwd Div Rate0.41 DKK

Trail. Div Rate0.41 DKK

Div. Yield0.61%

5Y Avg Yield0.20%

Payout Ratio21.35%

Ex-Div DateDec 4, 2025

Pay Date—

Splits

Last Split5:1

Split DateJan 3, 2018

Analyst Consensus

Rating2.8 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)81.77 DKK

Upside (mean)+21.2%

Target Range61.00 DKK – 116.40 DKK

61.00+21.2% to mean116.40

# Analysts7

Ownership

Shares Out.226.33M

Float181.36M

Insiders0.00%

Institutions27.70%

Technical

SMA 5070.65 (-4.5%)

SMA 20072.31 (-6.7%)

Beta1.39

S&P 52W Chg14.58%

Avg Vol (30d)1.01M

Avg Vol (10d)672.17K

Technical Indicators

RSI (14)46.7

MACD-0.4738

MACD Signal-0.7953

MACD Hist.+0.3215

BB Upper69.88 DKK

BB Middle66.91 DKK

BB Lower63.93 DKK

BB Width8.88%

ATR (14)1.943 DKK

Vol Ratio (20d)0.81x